PrestoDoctor

JUNE 2, 2020

Forecasts state that the medical marijuana market will be worth more than $8 billion by 2024, and the global medical cannabis market is predicted to reach a net worth of $73.6 A medical marijuana card allows users to purchase, carry, and medicate with cannabis legally. Informing Yourself on the Benefits of Medical Cannabis.

Marijuana 52

Marijuana Epilepsy Conditions Chronic Pain 52

SpeedWeed

MARCH 6, 2021

Proposals to cap the amount of THC in cannabis flower and concentrates have been gaining traction in a number of state legislatures, and earlier this week the idea reached the federal level. Cornyn and Feinstein are longtime opponents of cannabis legalization. Cornyn have indicated their support for descheduling cannabis.

THC 52

THC Patients Law Chronic Pain 52

Otherside Farms

JANUARY 25, 2019

When you consider that the majority of MMJ patients suffer from chronic pain (88% in Colorado) and that narcotic pain medications are dirt cheap when purchased through legitimate channels, it doesn’t take a high IQ to figure out that the pharmaceutical companies would love to corner this market.

Marijuana 68

Marijuana Strains Medicine Chronic Pain 68

Cannabis Law Report

JANUARY 5, 2022

The issued claims protect the use of MYMD-1 in a method of treatment for the progressive and generalized loss of skeletal muscle mass and strength known as sarcopenia. MYMD-1 also shows promise in pre-clinical studies as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-proliferation therapeutic.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

Our treatment designed for delaying aging has a distinctive drug profile of oral delivery, selectivity, and very low toxicity as compared with TNF blockers, all of which are delivered by injection only. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Medical Cannabis Seedbank

APRIL 25, 2018

When we do research into cannabis, we find that the topic of Sativa vs. Indica to either be misunderstood or the information we find to be very vague. In this post, we will get a better understanding by looking at the detailed differences between the two species of cannabis. There is an ongoing scientific debate about cannabis.

Indica 40

Indica Sativa Ruderalis Strains 40

Cannabis Law Report

JUNE 14, 2019

Cannabis Director Holly Bell will be responsible for overseeing the organization of the committee. Barry Gordon, MD is one of Florida’s most experienced medical cannabis providers. He is the owner and Chief Medical Officer of the Compassionate Cannabis Clinic. David Kotler is a partner in Cohen Kotler P.A. Dr. David B.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

JUNE 26, 2019

In this, her first article for CLR, she highlights for us who’s who and what’s what with regard to medical cannabis in the state. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years. David Kotler.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

The Cannigma

MARCH 12, 2021

Listen & Subscribe: Very few medical cannabis advocates are against the full legalization of the plant for all adults. In this episode of The Cannabis Enigma Podcast, host Michael Schaeffer Omer-Man interviews Dr. Fisher about the various ways medical and adult-use cannabis markets interact. Dr. Ruth Fisher. Music by Desca.

Legalization 128

Legalization Patients Education Dispensary 128

Alchimia

FEBRUARY 1, 2022

CBD is one of the principal cannabinoids found in cannabis and, along with THC, one of its best-known compounds. Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis. Anxiolytic : can help reduce anxiety and stress levels. Does CBD have any side effects?

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. The SAFE Banking Act (H.R.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

SEPTEMBER 10, 2019

(The legality of investing in cannabis in the UK is a bit dubious, according to a BBC Radio 4 report last week.). Cannaray’s two announcements are sure to promote the company’s standing in the European medical cannabis as well as cannabidiol scene. Cannabidiol, known as CBD, is a key chemical present in plants like cannabis and hemp.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Medical Cannabis Seedbank

AUGUST 6, 2018

Medical Cannabis research has boomed in the last decade with Israel being the pioneer. They have noted the Cannabis plant as a great option for a number of conditions. Research now has shown that Cannabis is no longer a “possible” solution to ailments but rather has solid proven results. 2) Canada- big companies.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. For a long time, it was the only viable (legal) cannabis entity in the country. .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

NORML

FEBRUARY 8, 2019

House Financial Services Committee is scheduled to hold a hearing on cannabis business banking issues next week. Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. So was a Mississippi medical cannabis proposal.

Legislation 178

Legislation Decriminalization Patients Access 178

Cannabis Law Report

NOVEMBER 22, 2019

The House Education & Labor Committee approved a bill to repeal the Higher Education Act Aid Elimination Penalty, a federal law that has stripped college financial aid from hundreds of thousands of students with convictions for cannabis or other drugs. They do not have jurisdiction over vaping and vape shops, for example.”.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. This white paper offers a primer to the complex and confusing global cannabis industry as it stands today.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 30, 2019

In this week’s edition: The US House passes bipartisan measure to prevent the Department of Justice from interfering with state medical and adult-use cannabis laws. The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

NOVEMBER 29, 2021

Specifically, legislatures in five states — Connecticut, New Jersey, New Mexico, New York, and Virginia — enacted laws legalizing adult-use marijuana possession and regulating retail cannabis markets. With respect to medical cannabis policies, numerous legislatures took steps in 2021 to expand patients’ access to marijuana products.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

FEBRUARY 11, 2022

Hope soared with the possibility of federal cannabis reform in 2021. But, as 2021 continued on, optimism dwindled as any advancement in federal cannabis reform was hobbled by the inability of Congress to agree on the appropriate level of reform and the proper mechanics for passage. Still, momentum for reform has not been lost.

Banking 59

Banking Decriminalization Cannabis Programs 59

Cannabis Law Report

OCTOBER 19, 2021

The new bills and attached report language announced by Senate Appropriations Committee Chairman Patrick Leahy (D-VT), which are part of a package of legislation to fund the federal government for Fiscal Year 2022, also contain several additional cannabis-related provisions. Read more at [link]. NORML write. statehood, which would give D.C.

Packaging 52

Packaging Legalization Research and Development Programs 52